Colorectal Cancer | Topics

 
Total Neoadjuvant Therapy Improves Rates of Pathological Complete Response in Rectal Cancer
January 22, 2021

Research published in JAMA Network Open found that total neoadjuvant therapy enhanced pathological complete response rates for patients with locally advanced rectal cancer.

TAS-102 Plus Bevacizumab Leads to Improved OS in Patients With mCRC Ineligible for Intensive Therapy
January 17, 2021

When compared with standard capecitabine and bevacizumab therapy, patients with unresectable metastatic colorectal cancer saw an increase in overall and progression-free survival.

Targeted Intervention Necessary for Low Health-Related Quality of Life Scores in Young Survivors of Colorectal Cancer
January 16, 2021

Data presented at the 2021 ASCO Gastrointestinal Cancers Symposium found that health-related quality of life among younger survivors of colorectal cancer is poor and social and functional well-being are also suffering as treatment durations increase.